Our previous studies also have shown that genetic variants of genes involved in the p53 pathway, such as p53, p73 and MDM2, can modify the association of SCCHN risk with HPV seropositivity [26-28]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.